No.4
公告
2026/10/21 21:53
事業の狀況
VOLUNTARY ANNOUNCEMENT PHASE III CLINICAL STUDY DATA OF ANAPRAZOLE SODIUM FOR REFLUX ESOPHAGITIS PRESENTED AT UEG WEEK 2026PRESENTED AT UEG WEEK 2026
VOLUNTARY ANNOUNCEMENT PHASE III CLINICAL STUDY DATA OF ANAPRAZOLE SODIUM FOR REFLUX ESOPHAGITIS PRESENTED AT UEG WEEK 2026PRESENTED AT UEG WEEK 2026